Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer care Lunit, a leading provider of AI-powered
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast
A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve
A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a
A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a
Fuel up with free Health Tech Insights
